Congenital Heart Diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: neonates and infants undergoing cardiac surgeries with cardiopulmonary bypass in our institution
Exclusion criteria
Exclusion criteria: cases of written informed consent not obtained from the parent of the patient
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) the platelet counts and fibrinogen levels at several time points: cessation of CPB, at cessation of modified ultrafiltration (MUF), after sternum closure and on admission in ICU (intensive care unit) 2) intraoperative transfusion volume 3) intraoperative bleeding count following the cessation of CPB 4) thrombotic complication | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) the platelet count and fibrinogen levels on the next day after the surgery 2) transfusion volume during 12 hours after the surgery 3) bleeding count during 12 hours after the surgery 4) length of stay in the ICU 5) postoperative complication and mortality | — |
Countries
Japan
Contacts
Gifu Prefecturel General Medical Center Department of Anesthesiology